X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (72) 72
oncology (66) 66
female (56) 56
aged (54) 54
male (52) 52
middle aged (50) 50
index medicus (48) 48
chemotherapy (43) 43
adult (40) 40
lung neoplasms - drug therapy (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
carcinoma, non-small-cell lung - drug therapy (33) 33
aged, 80 and over (30) 30
treatment outcome (30) 30
survival (23) 23
carcinoma, non-small-cell lung - genetics (22) 22
deoxycytidine - administration & dosage (21) 21
deoxycytidine - analogs & derivatives (21) 21
lung neoplasms - genetics (21) 21
cancer (19) 19
respiratory system (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
disease-free survival (17) 17
lung neoplasms - pathology (17) 17
carcinoma, non-small-cell lung - pathology (16) 16
mutation (16) 16
prognosis (16) 16
neoplasm staging (15) 15
lung cancer (14) 14
gefitinib (13) 13
hematology, oncology and palliative medicine (13) 13
neoplasm metastasis (13) 13
receptor, epidermal growth factor - genetics (13) 13
cisplatin (12) 12
colorectal neoplasms - drug therapy (12) 12
colorectal neoplasms - pathology (12) 12
fluorouracil - administration & dosage (12) 12
survival analysis (12) 12
antineoplastic agents - therapeutic use (11) 11
care and treatment (11) 11
cisplatin - administration & dosage (11) 11
organoplatinum compounds - administration & dosage (11) 11
disease progression (10) 10
leucovorin (10) 10
lung cancer, non-small cell (10) 10
metastasis (10) 10
non-small-cell lung cancer (10) 10
trial (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
capecitabine (9) 9
carcinoma (9) 9
colorectal cancer (9) 9
irinotecan (9) 9
kaplan-meier estimate (9) 9
lung neoplasms - mortality (9) 9
non-small cell lung cancer (9) 9
oxaliplatin (9) 9
protein kinase inhibitors - therapeutic use (9) 9
pulmonary/respiratory (9) 9
taxoids - administration & dosage (9) 9
therapy (9) 9
adenocarcinoma (8) 8
brca1 (8) 8
carcinoma, non-small-cell lung - mortality (8) 8
combination (8) 8
drug administration schedule (8) 8
fluorouracil (8) 8
fluorouracil - analogs & derivatives (8) 8
messenger-rna expression (8) 8
prospective studies (8) 8
quinazolines - therapeutic use (8) 8
research (8) 8
spain (8) 8
bevacizumab (7) 7
brca1 protein - genetics (7) 7
clinical trials (7) 7
egfr mutations (7) 7
erlotinib (7) 7
erlotinib hydrochloride (7) 7
genetic aspects (7) 7
health aspects (7) 7
medicine & public health (7) 7
open-label (7) 7
receptor, epidermal growth factor - antagonists & inhibitors (7) 7
survival rate (7) 7
1st-line treatment (6) 6
breast-cancer (6) 6
camptothecin - administration & dosage (6) 6
camptothecin - analogs & derivatives (6) 6
cancer patients (6) 6
cancer research (6) 6
carboplatin - administration & dosage (6) 6
cetuximab (6) 6
combined modality therapy (6) 6
deoxycytidine - adverse effects (6) 6
gemcitabine (6) 6
metastases (6) 6
nsclc (6) 6
paclitaxel - administration & dosage (6) 6
phase-iii (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
Journal of Thermophysics and Heat Transfer, ISSN 0887-8722, 04/2018, Volume 32, Issue 2, pp. 353 - 368
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2013, Volume 13, Issue 1, pp. 427 - 427
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3138 - 3145
Journal Article
AIP Conference Proceedings, ISSN 0094-243X, 08/2019, Volume 2132, Issue 1
In this paper, results of the simulation tools URANUS and PICLas are compared to Plasma wind tunnel experiments. This is done for validation purposes of... 
Monte Carlo method | Wind tunnel testing | Simulation | Wind tunnels | Computer simulation | Uranus | Modelling | Catalysis | Experiments
Journal Article
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 12/2010, Volume 8, Issue 1, pp. 135 - 135
Journal Article
The Oncologist, ISSN 1083-7159, 01/2012, Volume 17, Issue 1, pp. 15 - 25
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2005, Volume 11, Issue 16, pp. 5878 - 5885
Journal Article